Phase 4 Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any gender
- People who have been diagnosed with chronic plaque-type psoriasis
- People whose psoriasis covers between 2% and 10% of their body surface area
- People whose doctor has rated their psoriasis as a score of 2 or higher on a standard severity scale called the Physician Global Assessment
- People who have been receiving treatment with either etanercept or adalimumab (specific types of psoriasis medication) for at least 24 weeks
Who may not be able to join:
- People whose psoriasis covers less than 2% or more than 10% of their body surface area
- People whose doctor has rated their psoriasis below a score of 2 on the Physician Global Assessment scale
- People who are not currently receiving etanercept or adalimumab, or who have been receiving either of these medications for less than 24 weeks
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 6094434500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PGA x BSA improvement
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.